• down
  • down

    http://fontup.grandfontaine.eu/en/product/

Laboratoires Grand Fontaine

As a result of years of biomedical research in relation to Epigallocatechin-3-gallate (EGCG), Laboratoires Grand Fontaine has developed FontUp®, the first nutritional formula with a standardized amount of EGCG and rich in fibre.

Agreement with Down España

downespana
Laboratoires Grand Fontaine and Down España sign an agreement of collaboration
DOWN ESPAÑA is a NGO founded in 1991, which was conceived to promote the improvement of the living conditions of people with Down syndrome and their families. As a group, DOWN ESPAÑA gathers 88 Down syndrome institutions, spread throughout all the country.
More information: www.sindromedown.net 

Grand Fontaine attend to the t21 Research Society

t21
Laboratoires Grand Fontaine attended the first International Conference of the Trisomy 21 Research Society with a view to keeping up to date with current research and news regarding the Down syndrome, on 4-7 June 2015 in Paris.
The Trisomy 21 Research Society (T21RS) is the first non-profit scientific research organization to be focused on DS. It was founded to promote basic and translational investigation into DS and apply this new scientific knowledge to developing better treatments and cures. A large number of investigations about the capability of EGCG to regulate the overexpression of the DYRK1A gene were presented.
The presentation by Dr. Rafael de La Torre: “Tools for assessment of therapeutic approaches. Clinical trials for DS” underlined its cognitive performance in DS. He presented the utility of neuroimaging, neurophysiology and biomarker (biochemical, genetic) tools in the brain activity measured in Down syndrome, used in the TESTAD study.
Parallely, Dr. Mara Dierssen presented: “Remodeling the neuronal forest in intellectual disability”. This study is focused on the impact that neuropsychological functions such as memory and orientation in a DS mouse model (Ts65Dn y TgDyrk1A) may cause to the neuronal structure. This last research was financed by the Jerôme Lejeune Foundation and the Spanish Ministry of Science and Innovation.

Read More

Further information:
http://www.t21rs.org/

Information intended solely for health professionals to prescribe or supply medicines in Spain.

×